Legal Opinion
Daiichi Sankyo Co. v. Mylan Pharmaceuticals Inc.
District Court, D. New Jersey
Decided July 30, 2009No. Civ. 06-3462, 07-3039, 08-2752PublishedCited by 3 opinions
1Opinion of the Court
OPINION
MARTINI, District Judge.
Plaintiffs Daiichi Sankyo Company, Limited and Daiichi Sankyo, Inc. (collectively “Daiichi Sankyo”) are the inventors and producers of olmesartan medoxomil, the active ingredient in the hypertension medications Benicar, Benicar HCT, and Azor. Defendants Mylan Pharmaceuticals Inc., Mylan Laboratories Inc., Matrix Laboratories, LTD., and Mylan, Inc. (collectively “Mylan”) are drug manufacturers seeking to market a generic version of olmesartan medoxomil. Daiichi Sankyo filed this suit claiming infringement of its United States Patent No. 5,616,599 (“the '599…
2Cases cited35 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Stratoflex, Inc. v. Aeroquip CorporationCourt of Appeals for the Federal Circuit · 1983
- Colorado v. New MexicoSupreme Court of the United States · 1984
- Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
30 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Daiichi Sankyo Co., Ltd. v. MATRIX LABORATORIESCourt of Appeals for the Federal Circuit · 2010
- Apotex, Inc. v. Daiichi Sankyo, Inc.Court of Appeals for the Federal Circuit · 2015
- BTG Int'l Ltd. v. Amneal Pharm. LLCDistrict Court, D. New Jersey · 2018